Clinical Observation On The Treatment Of Mild Cognitive Impairment After Ischemic Stroke With Large Autogenous Blood Supply

ObjectiveBy observing the changes of MoCA and MMSE scale scores of patients with mild cognitive impairment after ischemic stroke before and after treatment with trioxy large autologous blood,the clinical efficacy of trioxy large autologous blood in the treatment of mild cognitive impairment after ischemic stroke was explored.MethodsIncorporated in October 2017,in April 2018,in the center of shenyang medical school affiliated hospital neurology treated up to the standard of the row of 50 patients with mild cognitive impairment after ischemic stroke,digital table method were randomly divided into experimental group and the control group(n = 25),before the treatment of patients with cognitive function score and record,the control group given the antithrombotic drug treatment,the experimental group in the control group on the basis of drug treatment by ozone treatment,10 days after the rating on the cognitive function of patients with the experimental group and the control group and record,compared two groups of cognitive function score changes,To explore the clinical efficacy and safety of treating mild cognitive impairment after ischemic stroke with large autogenous blood.ResultsBefore and after treatment,MoCA scale scores of the experimental group and control group showed no statistically significant difference(P>0.05).After treatment,MoCA scores of the experimental group and the control group showed statistically significant differences(P<0.05).There was no significant difference in MMSE scores between the two groups before and after treatment,and between the experimental group and the control group before treatment(P>0.05).After treatment,there were statistically significant differences in MMSE scores between the experimental group and the control group(P<0.05).MoCA and MMSE scores before and after treatment in the experimental group and before and after treatment in the experimental group showed statistically significant differences(P<0.05),MoCA and MoCA scores of the control group before and after treatment,and those of the control group before and after treatment,showed no statistically significant difference(P>0.05).MOCA scores in the treatment group were higher than those in the control group.MoCA score in the experimental group was higher after treatment than before treatment.After treatment,MMSE score in the experimental group was higher than that in the control group.In the experimental group,MMSE score was higher after treatment than before treatment.ConclusionsTreatment with trioxy large autologous blood can improve the symptoms of mild cognitive impairment after ischemic stroke.Compared with simple drug treatment,treatment with trioxy large autologous blood is effective for mild cognitive impairment after ischemic stroke.